BIND THERAPEUTICS INC's ticker is BINDQXXXX and the CUSIP is 05548N107. A total of 35 filers reported holding BIND THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $850,000 | -5.8% | 386,285 | -1.9% | 0.00% | 0.0% |
| Q4 2015 | $902,000 | -24.9% | 393,822 | +46.2% | 0.00% | -33.3% |
| Q3 2015 | $1,201,000 | -40.2% | 269,300 | -25.1% | 0.00% | -40.0% |
| Q2 2015 | $2,009,000 | +237.6% | 359,400 | +231.6% | 0.01% | +400.0% |
| Q1 2015 | $595,000 | – | 108,368 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 2,018,253 | $9,001,000 | 6.13% |
| FNY Managed Accounts LLC | 30,000 | $133,800,000 | 0.37% |
| Rhenman & Partners Asset Management AB | 133,535 | $596,000 | 0.10% |
| THOMPSON DAVIS & CO., INC. | 4,500 | $20,000 | 0.03% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 26,000 | $116,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 83,593 | $373,000 | 0.01% |
| VANGUARD GROUP INC | 5,488,396 | $177,885,000 | 0.01% |
| Alyeska Investment Group, L.P. | 114,786 | $512,000 | 0.01% |
| Renaissance Technologies | 269,300 | $1,201,000 | 0.00% |
| PRINCIPAL FINANCIAL GROUP INC | 324,900 | $1,449,000 | 0.00% |